Imugene

(OTC) IUGNF

Current Price$0.06

Market Cap$38.04M

Since IPO (2019)-46%

5 Year-99%

1 Year-91%

1 Month-47%

Imugene Financials at a Glance

Market Cap

$38.04M

Revenue (TTM)

$1.30M

Net Income (TTM)

$187.79M

EPS (TTM)

$-0.14

P/E Ratio

-0.63

Dividend

$0.00

Beta (Volatility)

-2.48 (Low)

Dividend

$0.00

Beta (Volatility)

-2.48 (Low)

Price

$0.06

Volume

5,000

Open

$0.06

Price

$0.06

Volume

5,000

Open

$0.06

Previous Close

$0.06

Daily Range

$0.06 - $0.06

52-Week Range

$0.01 - $0.83

Dividend

$0.00

Beta (Volatility)

-2.48 (Low)

Price

$0.06

Volume

5,000

Open

$0.06

Previous Close

$0.06

Daily Range

$0.06 - $0.06

52-Week Range

$0.01 - $0.83

IUGNF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Imugene

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Leslie Chong

Website

imugene.com

Headquarters

Sydney, NSW 2000, AU

IUGNF Financials

Key Financial Metrics (TTM)

Gross Margin

-66%

Operating Margin

-20%

Net Income Margin

-19%

Return on Equity

-113%

Return on Capital

-1%

Return on Assets

-86%

Earnings Yield

-1.59%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$38.04M

Shares Outstanding

415.83M

Volume

5.00K

Avg. Volume

17.49K

Financials (TTM)

Gross Profit

$4.40M

Operating Income

$70.94M

EBITDA

$67.42M

Operating Cash Flow

$75.57M

Capital Expenditure

$14.46M

Free Cash Flow

$90.03M

Cash & ST Invst.

$21.94M

Total Debt

$10.65M

Imugene Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$5.20M

-164.5%

Gross Margin

0.00%

N/A

Market Cap

$38.04M

N/A

Market Cap/Employee

$7.61M

N/A

Employees

N/A

Net Income

$37.81M

+45.0%

EBITDA

$40.06M

+42.1%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Net Cash

$9.11M

-93.1%

Accounts Receivable

$4.41M

-78.4%

Inventory

$1.67M

N/A

Long Term Debt

$48.23K

-98.8%

Short Term Debt

$4.97M

+115.1%

Return on Assets

-86.46%

N/A

Return on Invested Capital

-1.25%

N/A

Free Cash Flow

$25.96M

+56.7%

Operating Cash Flow

$25.96M

+46.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

PRNAFAlterity Therapeutics Limited

PRNAFAlterity Therapeutics Limited$0.00+0.00%

BSEMBioStem Technologies, Inc.

BSEMBioStem Technologies, Inc.$4.37-0.68%

VSBCVitaSpring Biomedical Co. Ltd.

VSBCVitaSpring Biomedical Co. Ltd.$0.01+0.00%

HSCHFH-Source Holdings Ltd.

HSCHFH-Source Holdings Ltd.$0.00+0.00%

SPHRYStarpharma Holdings Limited

SPHRYStarpharma Holdings Limited$5.00-0.60%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

DGXXDigi Power X

DGXXDigi Power X$5.11+0.29%

NOKNokia

NOKNokia$13.42+0.02%

PLTRPalantir Technologies

PLTRPalantir Technologies$135.91-0.07%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.96-0.02%

CCLCarnival Corp.

CCLCarnival Corp.$25.77+0.00%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.81+0.02%

RIGTransocean

RIGTransocean$6.25-0.09%

Questions About IUGNF

What is the current price of Imugene?

Imugene is trading at $0.06 per share.

What is the 52-week range for Imugene?

Over the past 52 weeks, Imugene has traded between $0.01 and $0.83.

How much debt does Imugene have?

As of the most recent reporting period, Imugene reported total debt of $6.98M.

How much cash does Imugene have on hand?

Imugene reported $14.38M in cash and cash equivalents in its most recent financial results.

What is Imugene’s dividend yield?

Imugene does not currently have a dividend yield.

Imugene

Imugene Financials at a Glance

IUGNF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Imugene

IUGNF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Imugene Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About IUGNF

What is the current price of Imugene?

What is the 52-week range for Imugene?

How much debt does Imugene have?

How much cash does Imugene have on hand?

What is Imugene’s dividend yield?

Premium Investing Services